![](/img/cover-not-exists.png)
Phase II studies of topotecan in patients with non-small cell lung cancer (NSCLC) previously untreated and patients with small cell lung (SCLC) cancer refractory to etoposide
Volume:
11
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/0169-5002(94)94255-2
Date:
June, 1994
File:
PDF, 132 KB
english, 1994